Inventor · disambiguated record
Alan Kraker
Also filed as: KRAKER ALAN · KRAKER ALAN J
7 granted patents·2 pending applications·1,899 citations·filing 1994–2005
92Inventor score
Top patents by PatentIndex Score
9 records- 0198US6455534B2Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 2001·Granted Sep 24, 2002·274 cites·18 claims
- 0298US5654307ABicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Aug 5, 1997·479 cites·2 claims
- 0397US6265410B1Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1998·Granted Jul 24, 2001·306 cites·45 claims
- 0497US6084095ASubstituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 4, 2000·292 cites·2 claims
- 0597US5679683ATricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Oct 21, 1997·306 cites·2 claims
- 0696US6596726B1Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 22, 2003·232 cites·10 claims
- 0778US7094798B1Inhibitors of checkpoint kinases (Wee1 and Chk1)PFIZER·Filed 2003·Granted Aug 22, 2006·10 cites·9 claims
- 0857US2005037476A1Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereofPFIZER·Filed 2004·Application pending·0 cites
- 0944US2005250836A1Inhibitors of checkpoint kinases (Wee1 and Chk1)PFIZER·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan Kraker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →